Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa

Clinical trial NCT06205602 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06205602
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2025-01-17
Primary completion: 2029-02-16
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.